Hemithoracic Radiotherapy for Mesothelioma
| | | |

Hemithoracic Radiotherapy for Mesothelioma

A type of radiation therapy called hemithoracic radiotherapy could be safely used as part of the treatment plan for patients with malignant pleural mesothelioma (MPM). Malignant pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers the lungs and chest wall. This cancer is caused by exposure to asbestos. Pleural mesothelioma occurs in about 2,000 people in the United States every year. Diagnosis typically occurs in people over the age of 60, but pleural mesothelioma has occurred in people in their twenties. Surgery, Chemotherapy and Radiation A study conducted in Turkey looked at 11 patients with mesothelioma who received multimodal therapy. This type of treatment plan uses more than one type of therapy…

Hemithoracic Radiotherapy for Mesothelioma
| | | |

Hemithoracic Radiotherapy for Mesothelioma

A type of radiation therapy called hemithoracic radiotherapy could be safely used as part of the treatment plan for patients with malignant pleural mesothelioma (MPM). Malignant pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers the lungs and chest wall. This cancer is caused by exposure to asbestos. Pleural mesothelioma occurs in about 2,000 people in the United States every year. Diagnosis typically occurs in people over the age of 60, but pleural mesothelioma has occurred in people in their twenties. Surgery, Chemotherapy and Radiation A study conducted in Turkey looked at 11 patients with mesothelioma who received multimodal therapy. This type of treatment plan uses more than one type of therapy…

Less Invasive Multimodal Treatment for Mesothelioma
|

Less Invasive Multimodal Treatment for Mesothelioma

A less invasive multimodal treatment for mesothelioma can lead to better survival. A team of German researchers discovered this after looking at 20 years of patient data. Mesothelioma is a rare form of cancer. It most often appears in older adults and is caused by exposure to asbestos. Asbestos is a toxic material that can be found in industrial and consumer products. Malignant pleural mesothelioma is a specific type of mesothelioma. It develops in the thin layer of tissue that covers the lungs and chest wall. Malignant pleural mesothelioma has three main subtypes: epithelioid, sarcomatoid, and mixed. Mesothelioma is also an aggressive cancer. It can be hard to treat because symptoms may not show up until decades after the asbestos…

The Link Between Surgery and Radiotherapy for Mesothelioma
| | |

The Link Between Surgery and Radiotherapy for Mesothelioma

A study from the Journal of Clinical Oncology has reviewed the link between radiotherapy and surgery. This is exciting new research in mesothelioma treatment. The study was conducted by mesothelioma experts in Australia. Malignant mesothelioma is a rare and aggressive cancer that rarely responds to a single cancer therapy. Malignant mesothelioma is almost always caused by exposure to asbestos. Usually, that happens in the workplace. Exciting New Research There is ongoing research exploring surgical options for mesothelioma. There are two common surgical procedures for mesothelioma: extrapleural pneumonectomy and pleurectomy decortication. Extrapleural pneumonectomy involves removing the lung affected by mesothelioma. Part of the diaphragm and the linings of the lung and heart are also removed. Pleurectomy decortication is a two-part surgical…

Surgery-Based Multimodal Treatment Improves Survival for Italian Mesothelioma Patients
| | | |

Surgery-Based Multimodal Treatment Improves Survival for Italian Mesothelioma Patients

A new Italian report suggests that a surgery-based multimodal treatment approach to mesothelioma can help patients live longer with few serious side effects.  The new study comes from Careggi University Hospital in Florence. Thoracic oncologists tracked the outcomes of 12 of their mesothelioma patients since 2017. All of the patients had early-stage pleural mesothelioma of the epithelioid subtype. Results showed that none of them died within the first year after surgery-based multimodal treatment. More than half lived for at least three years.  These are considered very positive results for a cancer that often claims lives within months of diagnosis.  Understanding Surgery-Based Multimodal Treatment Some types of cancer can be successfully treated with just one type of therapy. Pleural mesothelioma is…